A New Class of Multitargeting Pt IV Anticancer Agents: Prodrugs That Release Pt II Drugs and Bioactive Moieties Tethered to Pt IV via a Tertiary Amine
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c02501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Moumita Maji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel. Hauptthemen laut MEDLINE: Antineoplastic Agents, Prodrugs, Amines, Protein Kinase Inhibitors. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Israel Science Foundation.
Abstract (Originalsprache)
In most multi-action PtIV prodrugs previously reported, the bioactive molecules have carboxylate, hydroxyl, primary, or secondary amine groups through which they are tethered to the axial position of the PtIV directly or via self-immolative linkers. A major challenge is to expand the range to bioactive molecules that can be released in their active form from PtIV prodrugs to molecules having a tertiary amine. Herein, we describe the general approach for design and synthesis of PtIV complexes conjugated to organic drugs (brigatinib, osimertinib, adavosertib, and irinotecan) via their tertiary amines. The complexes are stable and release the active drugs upon reduction. The PtIV prodrugs conjugated to tyrosine kinase inhibitors (TKIs) showed potent anticancer activity in 2D and 3D cancer models by combining the modes of action of platinum and TKi. They inhibited in vivo tumor growth in an LLC model better than brigatinib, osimertinib, and cisplatin with significantly lower body weight loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, via Marzolo 5, Padova 35131, Italy.
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
ORCID-Profile: Moumita Maji, Sourav Acharya, Dan Gibson, Valentina Gandin
Förderung
- Israel Science Foundation
Zitieren
APA
Maji, M., De Franco, M., Acharya, S., Gibson, D., & Gandin, V. (2026). A New Class of Multitargeting Pt IV Anticancer Agents: Prodrugs That Release Pt II Drugs and Bioactive Moieties Tethered to Pt IV via a Tertiary Amine. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02501
Vancouver
Maji M, De Franco M, Acharya S, Gibson D, Gandin V. A New Class of Multitargeting Pt IV Anticancer Agents: Prodrugs That Release Pt II Drugs and Bioactive Moieties Tethered to Pt IV via a Tertiary Amine. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c02501
BibTeX
@article{Maji2026,
author = {Maji, Moumita and De Franco, Michele and Acharya, Sourav and Gibson, Dan and Gandin, Valentina},
title = {A New Class of Multitargeting Pt IV Anticancer Agents: Prodrugs That Release Pt II Drugs and Bioactive Moieties Tethered to Pt IV via a Tertiary Amine},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c02501}
}
EUVIMED